Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FUROSEMIDE\SPIRONOLACTONE Cause Aplastic anaemia? 42 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Aplastic anaemia have been filed in association with FUROSEMIDE\SPIRONOLACTONE. This represents 17.1% of all adverse event reports for FUROSEMIDE\SPIRONOLACTONE.

42
Reports of Aplastic anaemia with FUROSEMIDE\SPIRONOLACTONE
17.1%
of all FUROSEMIDE\SPIRONOLACTONE reports
0
Deaths
42
Hospitalizations

How Dangerous Is Aplastic anaemia From FUROSEMIDE\SPIRONOLACTONE?

Of the 42 reports, 42 (100.0%) required hospitalization.

Is Aplastic anaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FUROSEMIDE\SPIRONOLACTONE. However, 42 reports have been filed with the FAERS database.

What Other Side Effects Does FUROSEMIDE\SPIRONOLACTONE Cause?

Hyperkalaemia (82) Syncope (62) Acute kidney injury (53) Dyspnoea (52) Hyponatraemia (52) General physical health deterioration (51) Dyspepsia (50) Eructation (47) Joint dislocation (46) Mitral valve incompetence (46)

What Other Drugs Cause Aplastic anaemia?

ECULIZUMAB (345) CYCLOPHOSPHAMIDE (332) CYCLOSPORINE (331) METHOTREXATE (281) BUSULFAN (220) FLUDARABINE (220) ETOPOSIDE (186) VINCRISTINE (173) CYTARABINE (163) ELTROMBOPAG OLAMINE (149)

Which FUROSEMIDE\SPIRONOLACTONE Alternatives Have Lower Aplastic anaemia Risk?

FUROSEMIDE\SPIRONOLACTONE vs FUSIDATE FUROSEMIDE\SPIRONOLACTONE vs FUSIDIC ACID FUROSEMIDE\SPIRONOLACTONE vs FUTIBATINIB FUROSEMIDE\SPIRONOLACTONE vs GABAPENTIN FUROSEMIDE\SPIRONOLACTONE vs GABAPENTIN ENACARBIL

Related Pages

FUROSEMIDE\SPIRONOLACTONE Full Profile All Aplastic anaemia Reports All Drugs Causing Aplastic anaemia FUROSEMIDE\SPIRONOLACTONE Demographics